Menu
Search
|

Menu

Close
X

Daiichi Sankyo Co Ltd 4568.T (Tokyo Stock Exchange)

3,954.00 JPY
-89.00 (-2.20%)
As of 1:00 AM EST
chart
Previous Close 4,043.00
Open 3,984.00
Volume 1,589,800
3m Avg Volume 1,737,616
Today’s High 4,046.00
Today’s Low 3,951.00
52 Week High 5,032.00
52 Week Low 2,622.00
Shares Outstanding (mil) 709.01
Market Capitalization (mil) 2,996,282.00
Forward P/E 39.60
Dividend (Yield %) 35.00 ( 1.66 )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.58 Mean rating from 12 analysts

KEY STATS

Revenue (mm, JPY)
FY19
446,849
FY18
960,195
FY17
955,123
FY16
986,446
FY15
775,601
EPS (JPY)
FY19
67.797
FY18
90.485
FY17
78.371
FY16
118.308
FY15
19.569
*Note: Units in Millions of Yen
**Note: Units in Yen

KEY RATIOS

Price to Earnings (TTM)
vs sector
39.60
29.37
Price to Sales (TTM)
vs sector
3.20
20.58
Price to Book (MRQ)
vs sector
2.19
4.23
Price to Cash Flow (TTM)
vs sector
25.48
21.21
Total Debt to Equity (MRQ)
vs sector
20.88
13.84
LT Debt to Equity (MRQ)
vs sector
17.68
9.93
Return on Investment (TTM)
vs sector
4.36
13.58
Return on Equity (TTM)
vs sector
5.72
15.11

EXECUTIVE LEADERSHIP

Joji Nakayama
Chairman of the Board, Chief Executive Officer, Representative Director, Since 2017
Salary: --
Bonus: --
Sunao Manabe
Executive President, President, Chief Operating Officer, Representative Director, Since 2017
Salary: --
Bonus: --
Toshiaki Sai
Chief Financial Officer, Executive Vice President, Vice President, Chief Director of Business Strategy, Representative Director, Since 2018
Salary: --
Bonus: --
Kentaro Takamura
Managing Executive Officer, Director of Finance & Accounting in Main Business Strategy Unit, Since 2018
Salary: --
Bonus: --
Satoru Kimura
Senior Managing Executive Officer, Chief Director of Pharmaceutical Sales, Since 2016
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Pharmaceuticals
Address:

Daiichi Sankyo Bldg. A/B Kan
3-5-1, Nihombashi Hon-cho
CHUO-KU   TKY   103-8426

Phone: +813.62251111

DAIICHI SANKYO COMPANY, LIMITED is a Japan-based holding company mainly engaged in the manufacture and sale of pharmaceuticals. The Company is involved in the research, development, manufacture and sale of pharmaceuticals, as well as the provision of intermediates and basic materials for pharmaceutical producing in Japan, the United States, Europe and other markets. The Company is also engaged in the research, development, manufacture and sale of over-the-counter drugs and vaccines, the provision of administrative services such as human resources and accounting services, real estate leasing and insurance agency business.

SPONSORED STORIES